Jae-Ho Cheong

26PUBLICATIONS
146CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer diagnosisRegenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Sep 29, 2025
Neoadjuvant CTLA-4/PD-(L)1 Blockade Versus Surgery +/- Chemotherapy in Deficient Mismatch Repair/Microsatellite Instability-High Resectable Gastroesophageal Adenocarcinoma: Individual Patient Data Pooled Analysis.

Alessandra Raimondi, Gabriele Tinè, Alexej Ballhausen

|Jul 12, 2024
Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY.

Yoon-Koo Kang, Hyung-Don Kim, Jeong Hwan Yook

|May 30, 2024
Targeting ATP2B1 impairs PI3K/Akt/FOXO signaling and reduces SARS-COV-2 infection and replication.

Pasqualino de Antonellis, Veronica Ferrucci, Marco Miceli

|May 08, 2024
Risk of Subsequent Primary Cancers Among Adult-Onset 5-Year Cancer Survivors in South Korea: Retrospective Cohort Study.

Yoon Young Choi, Myeongjee Lee, Eun Hwa Kim

|Mar 18, 2024
Deciphering metastatic route-specific signals and their microenvironment interactions in peritoneal metastasis of gastric cancer.

Ki Tae Kim, Jae Eun Lee, Jae-Ho Cheong

Pageof 5